Değer202020212022202320242025TTMYatırım faaliyetlerinden elde edilen nakit-114.65 M156.16 M-232.93 M50.61 M-3.07 M-24.76 M-44.44 MFinansman faaliyetlerinden elde edilen nakit303.73 M329.18 M270.53 M911 K6.89 M28.54 M11.84 MSerbest nakit akışı-142.25 M-112.24 M-124.39 M-142.47 M-64.09 M-75.63 M-95.04 M
Twist Bioscience Corporation - Common Stock
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.